Dermatologist Exposes Sunscreen’s Missing Piece

Woman in a bathrobe with a towel on her head, smiling at her reflection in a mirror

Metabolic dysfunction inside your body might fuel skin cancer more than the sun ever could.

Story Snapshot

Dr. Teo Soleymani reveals metabolic health as a starring player in skin cancer risk, beyond UV exposure.
High blood pressure raises melanoma risk by 17-18%; obesity and high glucose link to nonmelanoma cancers.
UK Biobank study of 467,919 people finds little overall metabolic syndrome effect, but individual factors matter.
Squamous cell cancers show metabolic flexibility, resisting treatments by switching fuels.
Prevention must expand to lifestyle fixes optimizing blood pressure, glucose, and weight.

Dr. Soleymani Challenges UV-Only Focus

Dr. Teo Soleymani, double board-certified dermatologist, spotlights metabolic health’s overlooked role in skin cancer. He describes metabolism as a whole-body system impacting skin directly. Traditional prevention stresses sunscreen and shade. Soleymani argues poor metabolic markers like high blood pressure and elevated glucose create internal risks that compound UV damage. Patients with these issues face higher odds, urging doctors to check beyond skin checks.

UK Biobank Exposes Conflicting Data

UK Biobank researchers tracked 467,919 participants for up to 10.8 years. Metabolic syndrome showed little overall skin cancer effect. It even offered moderate protection against basal cell carcinoma. Squamous cell and melanoma links proved insignificant. Mendelian randomization detected weak causal evidence, with odds ratio of 1.07. These findings clash with metabolic syndrome’s strong ties to 14 other cancers. Observational biases likely confound results, demanding genetic scrutiny.

Individual Risks Outpace Syndrome Effects

A 12-year Metabolic Syndrome and Cancer Project study pinpointed specific culprits. High blood pressure linked to 17-18% higher malignant melanoma risk in men and women. Men’s obesity correlated with elevated nonmelanoma skin cancer rates. Women’s high glucose tied to more squamous cell carcinomas. These components act independently, not synergistically as full syndrome.

Mechanisms Link Metabolism to Cancer Growth

UCLA Broad Center researchers uncovered squamous cell carcinomas’ metabolic flexibility. Tumors switch nutrient sources, dodging single-drug attacks. Chronic obesity inflammation alters adipokines, hormones bridging fat and immunity. Shared markers like TNF-alpha, IL-6, leptin, and adiponectin fuel both insulin resistance and skin disorders. Skin itself acts as a metabolic organ, processing hormones and steroids. Disruptions here amplify cancer vulnerability through these pathways.

Metabolic syndrome defines five traits: large waist, hypertension, high triglycerides, low HDL cholesterol, high fasting glucose or diabetes. These overlap skin issues via inflammation. Psoriasis patients show dose-response ties to syndrome severity. Dermatologists stand ready to spot metabolic red flags early.

Prevention and Treatment Horizons Expand

Dermatologists now screen skin patients for metabolic issues, catching heart disease and diabetes precursors. Patients gain motivation for diet and exercise beyond sun hats. Long-term, messaging evolves to holistic health. Combination therapies target tumors’ fuel switches. Topical treatments could exploit skin cancers’ metabolic weaknesses safely. Over 20% with metabolic syndrome benefit most. Public health gains by blending UV and lifestyle advice effectively.